Latest news from Cochrane

• 

  New evidence questions the benefit of calcium supplements in pregnancy for preventing pre-eclampsia

  3 Dezember 2025

  An updated Cochrane review has found that calcium supplementation has no effect on pre-eclampsia, challenging long-held assumptions about the role of calcium in preventing hypertensive disorders in pregnancy.

• 

  New research confirms HPV vaccination prevents cervical cancer

  24 November 2025

  Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus.

• 

  What do we know about the HPV vaccine?

  24 November 2025

  Learn about HPV as we answer common questions and explore how vaccination can protect children.

• 

  How can public health professionals overcome vaccine hesitation?

  17 November 2025

  Vaccination against human papillomavirus (HPV) is one of the most effective tools for preventing cervical cancer in women and other HPV-associated diseases in people of all genders. Yet many people worldwide remain reluctant to take the vaccine.

• 

  Global evidence highlights social roots of HPV vaccine hesitancy

  17 November 2025

  Decisions about the HPV vaccine among adolescents and their families are influenced by a web of social, cultural and trust-related factors, beyond simple awareness or access

• 

  Common gout drug may reduce risk of heart attack and stroke

  12 November 2025

  A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review.

• 

  Setting the standards for responsible AI use in evidence synthesis

  11 November 2025

  Cochrane, the Campbell Collaboration, JBI, and the Collaboration for Environmental Evidence have published a joint position statement on the responsible use of artificial intelligence (AI) in evidence synthesis.

• 

  GLP-1 drugs effective for weight loss, but more independent studies needed

  30 Oktober 2025

  Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions.

• 

  What is Cochrane doing to strengthen research integrity?

  29 Oktober 2025

  We continue to lead the field in trustworthiness and transparency by evolving our practices to address the most pressing challenges in research integrity and publishing ethics, and to respond to rapid advances in technology. Here is a wrap up of recent developments in these areas.

• 

  Strong evidence supports skin-to-skin contact after birth as standard care

  22 Oktober 2025

  Immediate skin-to-skin contact between newborns and their mothers offers a better start in life, improving a number of key health metrics, according to a newly-updated Cochrane review.